BREANNA CARO: Open Payments
NPI 1992028476 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 21 payments from 10 companies in 2025. Trend: 2023 $818 · 2024 $1,079 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $161 |
| ABBVIE INC. | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $59 |
| Novo Nordisk Inc | 2 | $44 |
| Amgen Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Currax Pharmaceuticals LLC | 1 | $16 |
Products named: SPRAVATO, VRAYLAR, AIRSUPRA, LEQVIO, Kerendia, JARDIANCE, MOUNJARO, REPATHA.
Industry payments across CA — which companies pay providers there.
